Calcium Channel Blockers
The AANP exam tests calcium channel blockers by forcing you to choose between two subclasses with different organ targets. Dihydropyridines (amlodipine, nifedipine, felodipine) act on vascular smooth muscle — vasodilation, blood pressure reduction, peripheral edema as the signature side effect. Non-dihydropyridines (diltiazem, verapamil) act on cardiac conduction — heart rate reduction, AV node slowing, useful for rate control in atrial fibrillation. The combinations to avoid are non-DHPs with beta-blockers (additive bradycardia and AV block) and any CCB with grapefruit juice (CYP3A4 inhibition). Amlodipine is the workhorse antihypertensive when an ACE/ARB plus a thiazide isn't enough; diltiazem owns the rate-control questions when a beta-blocker is contraindicated.
📖 Overview
CCBs block L-type calcium channels, preventing calcium entry into vascular smooth muscle and/or cardiac myocytes. Dihydropyridines (amlodipine, nifedipine) are vessel-selective → good antihypertensives but can cause reflex tachycardia and peripheral edema. Non-dihydropyridines (diltiazem, verapamil) are heart-selective → used for rate control in atrial fibrillation and SVT.
⚙️ Mechanism of Action
DHP: L-type Ca²⁺ blockade in vascular smooth muscle → peripheral vasodilation, ↓BP. Non-DHP: L-type Ca²⁺ blockade in myocardium and AV node → ↓HR, ↓contractility, AV nodal slowing.
💎 Board Pearls
- 🦶 DHPs (amlodipine, nifedipine) → peripheral edema (dose-dependent; not fluid overload).
- 🍊 Grapefruit juice ↑ CCB levels via CYP3A4 inhibition.
- 🫀 Non-DHPs (diltiazem, verapamil) → avoid with beta-blockers (additive AV block).
- 🤰 Nifedipine = tocolytic + 2nd-line pregnancy HTN.
- 💩 Verapamil → constipation in ~25% of patients.
- 🚫 Non-DHPs contraindicated in HFrEF (negative inotropes worsen EF).
💊 Drugs in This Class
- Amlodipine — NorvascHTN, stable angina, vasospastic (Prinzmetal) angina.
- Nifedipine — Procardia, AdalatHTN (ER), chronic stable/vasospastic angina, TOCOLYSIS in preterm labor.
- Diltiazem — Cardizem, TiazacA-fib/a-flutter rate control, SVT, HTN, stable angina.
- Verapamil — Calan, VerelanSVT (paroxysmal), a-fib rate control, HTN, cluster headache prophylaxis, hypertrophic cardiomyopathy.
Practice Questions
Non-dihydropyridine calcium-channel blockers, such as diltiazem (Cardizem) and verapamil (Calan), should generally NOT be used in which of the following conditions?
Sources
Ready to practice?
1,500+ AANP-style questions with rationales — free trial.